COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,776 Articles (22,946 medRxiv, 8,830 bioRxiv)

Most recent first Previous |  Page 2013: Articles 20121-20130  | Next

From infection to immunity: understanding the response to SARS-CoV2 through in-silico modeling
Castiglione, F., Deb, D., Srivastava, A. P., Lio, P., Liso, A.
10.1101/2020.12.20.423670 — Posted: 2020-12-21
Evidence of a dysregulated Vitamin D pathway in SARS-CoV-2 infected patient's lung cells
George, B., Amjesh, R., Paul, A. M., Pillai, M. R., Kumar, R.
10.1101/2020.12.21.423733 — Posted: 2020-12-21
In vitro measurements of protein-protein interactions show that antibody affinity governs the inhibition of SARS-CoV-2 spike/ACE2 binding in convalescent serum
Fiedler, S., Piziorska, M. A., Denninger, V., Morgunov, A. S., Ilsley, A., Malik, A. Y., Schneider, M. M., Devenish, S. R. A., Meisl, G., Aguzzi, A., Fiegler, H., Knowles, T. P. J.
10.1101/2020.12.20.422820 — Posted: 2020-12-21
Fatty Acid Synthase inhibition prevents palmitoylation of SARS-CoV2 SpikeProtein and improves survival of mice infected with murine hepatitis virus.
Lee, M., Mekhail, K., Sugiyama, M., Latreille, E., Khosraviani, N., Wei, K., Lee, W. L., Antonescu, C. N., Fairn, G. D.
10.1101/2020.12.20.423603 — Posted: 2020-12-21
A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques.
Baisa, G., Rancour, D., Mansfield, K., Burns, M., Martin, L., Cunha, D., Fischer, J., Muecksch, F., Hatziioannou, T., Bieniasz, P., Schomburg, F., Luke, K.
10.1101/2020.12.20.422693 — Posted: 2020-12-21
Immunological and pathological outcomes of SARS-CoV-2 challenge after formalin-inactivated vaccine immunisation of ferrets and rhesus macaques
Bewley, K. R., Gooch, K. E. R., Thomas, K. M., Longet, S. R., Wiblin, N., Hunter, L., Chan, K., Brown, P., Russell, R. A., Ho, C., Slack, G., Humphries, H. E., Alden, L., Allen, L., Aram, M., Baker, N., Brunt, E., Cobb, R., Fotheringham, S., Harris, D., Kennard, C., Leung, S., Ryan, K. A., Tolley, H., Wand, N., White, A., Sibley, L., Sarfas, C., Pearson, G., Rayner, E., Xue, X., Lambe, T., Charlton, S., Gilbert, S. C., Sattentau, Q., Gleeson, F., Hall, Y., Funnell, S. G. P., Sharpe, S., Salguero, F. J., Gorringe, A. R., Carroll, M.
10.1101/2020.12.21.423746 — Posted: 2020-12-21
Minimizing exposure to respiratory droplets, 'jet riders' and aerosols in air-conditioned hospital rooms by a 'Shield-and-Sink' strategy
Hunziker, P.
10.1101/2020.12.08.20233056 — Posted: 2020-12-21
SARS-CoV-2 escapes CD8 T cell surveillance via mutations in MHC-I restricted epitopes
Agerer, B., Koblischke, M., Gudipati, V., Smyth, M., Popa, A., Genger, J.-W., Endler, L., Florian, D. M., Muehlgrabner, V., Lercher, A., Gattinger, P., Torralba-Gombau, R., Penz, T., Fae, I., Wenda, S., Traungott, M., Walder, G., Fischer, G., Hoepler, W., Pawelka, E., Zoufaly, A., Valenta, R., Bock, C., Huppa, J. B., Aberle, J. H., Bergthaler, A.
10.1101/2020.12.18.423507 — Posted: 2020-12-20
SARS-CoV-2 protein ORF3a is pathogenic in Drosophila and causes phenotypes associated with COVID-19 post-viral syndrome
Yang, S., Tian, M., Johnson, A. N.
10.1101/2020.12.20.423533 — Posted: 2020-12-20
Identification of NPC1 as a novel SARS-CoV-2 intracellular target
Garcia-Dorival, I., Cuesta-Geijo, M. A., Barrado-Gil, L., Galindo, I., Urquiza, J., Del Puerto, A., Gil, C., Campillo, N., Martinez, A., Alonso, C.
10.1101/2020.12.19.423584 — Posted: 2020-12-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).